Skip to main content
. 2022 Mar 4;38(3):169–173. doi: 10.1177/87551225221080027

Table 1.

Patient Demographics.

mAb (n = 568) Non-mAb (n = 1044) P value
Age (years), mean 62.8 60.7 0.0119
Gender, n (%)
 Male 224 (39) 418 (40) 0.8314
 Female 344 (61) 626 (60)
Race, n (%)
 Asian 0 (0) 4 (0.4) 0.3040
 Black 138 (24) 441 (42) <0.0001
 Hispanic 0 (0) 9 (1) 0.0313
 Other 19 (3) 30 (3) 0.6492
 White 404 (71) 550 (53) <0.0001
 Unknown 7 (1) 10 (1) 0.6161
Risk factors median 2 2
 Age ≥65 years, n (%) 281 (49) 498 (48) 0.4982
 BMI ≥35 kg/m2, n (%) 197 (35) 383 (37) 0.4471
 CKD, n (%) 36 (6) 155 (15) <0.0001
 DM, n (%) 188 (33) 381 (36) 0.1904
 Immunosuppressive disease, n (%) 65 (11) 143 (14) 0.2137
 Immunosuppressive treatment, n (%) 54 (10) 94 (9) 0.7866
 Age ≥55 cardiovascular disease, n (%) 158 (28) 321 (31) 0.2311
 Age ≥55 hypertension, n (%) 325 (57) 557 (53) 0.1427
 Age ≥55 chronic lung disease, n (%) 48 (8) 126 (12) 0.0287

Abbreviations: BMI, body mass index; CKD, chronic kidney disease; DM, diabetes mellitus; mAb, monoclonal antibody.

Bolded values indicate a statistically significant result.